Evidence map›Paper›PMID 23189151›Full record

ArticlePloS one2012

Snm1B interacts with PSF2.

Jay R Stringer, Christopher M Counter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jay R StringerDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
Christopher M Counter
Duke Medical Center · USDuke University Hospital · US

Funding

Dynamic requirements of Ras signaling during cancerR01CA123031 · NCI · DUKE UNIVERSITY · PI COUNTER, CHRISTOPHER M · 2007 to 2018
$3.5M
The Molecular Basis of Telomerase Function &RegulationR01CA082481 · NCI · DUKE UNIVERSITY · PI COUNTER, CHRISTOPHER M · 1999 to 2009
$2.7M
NCI NIH HHS CA082481NCI NIH HHS CA123031NCI NIH HHS R01 CA082481NCI NIH HHS R01 CA123031
6 · The paper itself

Abstract

The protein Snm1B plays a key role in interstrand crosslink (ICL) repair. In a yeast two-hybrid screen we identified the protein PSF2 to bind Snm1B. PSF2 is a member of the GINS complex involved in replication initiation and elongation, and is known to play a role in ICL repair. Snm1B was shown to bind PSF2 in human cells through two regions, strongly to a 144 amino acid N-terminal region and weakly to a second smaller 37 amino acid C-terminal region. Ectopic expression of PSF2 increased the amount of Mus81, a protein component of the endonucleolytic complex involved in ICL repair, co-immunoprecipitating with Snm1B. Moreover, deleting the N-terminal, but not C-terminal region of Snm1B reduced the amount of co-immunoprecipitated Mus81. Conversely, the telomere-binding protein TRF2 competed with PSF2 for binding to the C-terminus of Snm1B, and deletion of this region, but not the N-terminal region, reduced Snm1B chromatin association. We speculate that the N-terminal region of Snm1B forms a complex containing PSF2 and Mus81, while the C-terminal region is important for PSF2-mediated chromatin association.

Indexed as

ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 3Cell LineChromatinDNA-Binding ProteinsDNA Repair EnzymesEndonucleasesExodeoxyribonucleasesHumansImmunoprecipitationNuclear ProteinsProtein BindingProtein Interaction Domains and MotifsRecombinant Fusion ProteinsTwo-Hybrid System TechniquesATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 3ChromatinDCLRE1B protein, humanDNA-Binding ProteinsDNA Repair EnzymesEndonucleasesExodeoxyribonucleasesMUS81 protein, humanNuclear ProteinsRecombinant Fusion ProteinsTAP2 protein, human

Identifiers

PMID23189151
PMCPMC3506659
OpenAlexW2134148681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.